tradingkey.logo
tradingkey.logo
Search

Tonix Pharmaceuticals Holding Corp

TNXP
Add to Watchlist
11.870USD
-0.410-3.34%
Close 09-11 16:00ET
198.99MMarket Cap
LossP/E TTM

TNXP Income Statement

You can find the annual or quarterly income statement of Tonix Pharmaceuticals Holding Corp here for insights into the performance and operational efficiency of Tonix Pharmaceuticals Holding Corp.
Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q4
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
FY2012Q4
FY2012Q3
FY2012Q2
FY2012Q1
Total revenue
577.88%13.54M
183.16%6.88M
108.75%5.39M
16.58%3.29M
-9.51%2.00M
-2.14%2.43M
-31.68%2.58M
-29.26%2.82M
--2.21M
--2.48M
--3.78M
--3.99M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
Revenue
577.88%13.54M
183.16%6.88M
108.75%5.39M
16.58%3.29M
-9.51%2.00M
-2.14%2.43M
-31.68%2.58M
-29.26%2.82M
--2.21M
--2.48M
--3.78M
--3.99M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
----
----
----
----
----
----
----
----
Cost of revenue
-78.51%703.00K
67.34%1.58M
-10.57%1.06M
-12.09%1.37M
-2.82%3.27M
-43.19%943.00K
-50.02%1.18M
-34.50%1.56M
--3.37M
--1.66M
--2.37M
--2.37M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
85.12%56.08M
161.94%48.41M
114.17%53.68M
97.85%36.36M
47.29%30.29M
-22.45%18.48M
-19.44%25.06M
-42.82%18.38M
-29.08%20.57M
-29.70%23.83M
-4.95%31.11M
8.60%32.14M
24.28%29.00M
28.24%33.90M
11.02%32.73M
59.65%29.59M
-0.96%23.34M
27.49%26.44M
73.17%29.48M
54.47%18.54M
66.02%23.56M
184.17%20.74M
94.90%17.02M
52.06%12.00M
140.30%14.19M
15.88%7.30M
14.17%8.73M
42.41%7.89M
-3.86%5.91M
-9.89%6.30M
38.01%7.65M
-5.04%5.54M
27.40%6.14M
37.26%6.99M
-26.19%5.54M
-23.31%5.83M
-50.98%4.82M
-63.67%5.09M
-43.96%7.51M
-42.70%7.61M
-16.53%9.84M
44.53%14.01M
48.84%13.40M
78.64%13.28M
94.81%11.78M
87.58%9.70M
142.73%9.00M
140.45%7.43M
189.98%6.05M
158.29%5.17M
93.63%3.71M
78.26%3.09M
12.70%2.09M
72.47%2.00M
--1.92M
--1.73M
--1.85M
--1.16M
R&D expenses
79.45%19.42M
144.93%18.21M
104.18%16.94M
1.92%9.29M
11.57%10.82M
-42.19%7.44M
-51.54%8.30M
-56.70%9.11M
-55.87%9.70M
-51.48%12.86M
-30.62%17.12M
-5.18%21.05M
32.55%21.98M
43.91%26.51M
10.67%24.67M
69.71%22.20M
-8.57%16.58M
20.19%18.42M
84.31%22.30M
48.44%13.08M
71.54%18.13M
227.78%15.33M
112.60%12.10M
74.45%8.81M
197.44%10.57M
20.02%4.68M
12.52%5.69M
54.78%5.05M
-12.61%3.55M
-24.64%3.90M
39.16%5.06M
-16.48%3.26M
44.94%4.07M
72.68%5.17M
-25.53%3.63M
-28.50%3.91M
-62.67%2.81M
-71.94%2.99M
-48.58%4.88M
-47.00%5.47M
-15.27%7.52M
56.26%10.67M
64.33%9.49M
97.70%10.31M
117.69%8.87M
92.37%6.83M
334.68%5.78M
218.73%5.22M
331.67%4.08M
379.32%3.55M
89.86%1.33M
148.70%1.64M
14.04%944.00K
86.26%740.63K
--699.75K
--658.14K
--827.79K
--397.63K
Depreciation, depletion, and amortization
28.16%619.00K
21.70%600.00K
0.00%500.00K
-9.61%461.00K
-59.92%483.00K
-60.18%493.00K
-60.35%500.00K
-58.06%510.00K
30.84%1.21M
38.63%1.24M
50.84%1.26M
382.54%1.22M
802.94%921.00K
1317.46%893.00K
2996.30%836.00K
2420.00%252.00K
1357.14%102.00K
950.00%63.00K
285.71%27.00K
25.00%10.00K
16.67%7.00K
0.00%6.00K
40.00%7.00K
60.00%8.00K
-14.29%6.00K
-33.33%6.00K
-54.55%5.00K
-61.54%5.00K
-53.33%7.00K
-40.00%9.00K
-21.43%11.00K
-18.75%13.00K
50.00%15.00K
-37.50%15.00K
-67.44%14.00K
-68.00%16.00K
-82.14%10.00K
-57.89%24.00K
-39.44%43.00K
11.11%50.00K
143.48%56.00K
159.09%57.00K
238.10%71.00K
650.00%45.00K
360.00%23.00K
450.00%22.00K
340.53%21.00K
44.47%6.00K
26.84%5.00K
-3.33%4.00K
15.23%4.77K
1.89%4.15K
4.78%3.94K
75.79%4.14K
--4.14K
--4.08K
--3.76K
--2.35K
Operating profit
-50.32%-42.53M
-158.73%-41.54M
-114.80%-48.29M
-112.59%-33.07M
-54.13%-28.30M
24.81%-16.05M
17.74%-22.48M
44.74%-15.55M
36.70%-18.36M
37.02%-21.35M
16.50%-27.33M
4.88%-28.15M
-24.28%-29.00M
-28.24%-33.90M
-11.02%-32.73M
-59.65%-29.59M
0.96%-23.34M
-27.49%-26.44M
-73.17%-29.48M
-54.47%-18.54M
-66.02%-23.56M
-184.17%-20.74M
-94.90%-17.02M
-52.06%-12.00M
-140.30%-14.19M
-15.88%-7.30M
-14.17%-8.73M
-42.41%-7.89M
3.86%-5.91M
9.89%-6.30M
-38.01%-7.65M
5.04%-5.54M
-27.40%-6.14M
-37.26%-6.99M
26.19%-5.54M
23.31%-5.83M
50.98%-4.82M
63.67%-5.09M
43.96%-7.51M
42.70%-7.61M
16.53%-9.84M
-44.53%-14.01M
-48.84%-13.40M
-78.64%-13.28M
-94.81%-11.78M
-87.58%-9.70M
-142.73%-9.00M
-140.45%-7.43M
-189.98%-6.05M
-158.29%-5.17M
-93.63%-3.71M
-78.26%-3.09M
-12.70%-2.09M
-72.47%-2.00M
---1.92M
---1.73M
---1.85M
---1.16M
Net non-operating interest income (expenses)
Non-operating interest income
----
--1.35M
--1.34M
--1.23M
----
----
----
----
----
----
----
-71.80%172.00K
229.59%646.00K
4621.05%897.00K
--1.05M
8614.29%610.00K
2077.78%196.00K
-77.11%19.00K
----
-22.22%7.00K
-30.77%9.00K
245.83%83.00K
--2.00K
--9.00K
--13.00K
--24.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Non-operating interest expense
----
----
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
----
----
--0.00
--0.00
----
-129.86%-2.09M
--0.00
--0.00
---59.81M
--7.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
----
-100.00%0.00
--0.00
--0.00
---1.22M
--47.02K
Other non-operating income (expenses)
159.96%551.00K
-100.23%-3.00K
-91.40%32.00K
-112.98%-174.00K
-51.90%-919.00K
322.09%1.32M
5214.29%372.00K
--1.34M
---605.00K
---593.00K
--7.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
----
--0.00
--0.00
--1.88K
----
----
Income before tax
-43.44%-40.55M
-138.84%-40.19M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
13.76%-27.32M
3.47%-27.98M
-22.54%-28.36M
-24.94%-33.01M
-7.20%-31.68M
-56.42%-28.98M
1.75%-23.14M
-27.91%-26.42M
-73.63%-29.55M
-54.53%-18.53M
-66.11%-23.55M
-183.97%-20.65M
-95.49%-17.02M
-52.97%-11.99M
-142.79%-14.18M
-16.69%-7.27M
-14.75%-8.71M
-43.06%-7.84M
4.06%-5.84M
10.12%-6.23M
-38.14%-7.59M
5.31%-5.48M
-27.34%-6.09M
-36.95%-6.94M
26.58%-5.49M
23.65%-5.79M
51.25%-4.78M
63.77%-5.06M
44.00%-7.48M
42.81%-7.58M
16.64%-9.81M
-44.37%-13.98M
-48.63%-13.36M
-78.60%-13.25M
-94.62%-11.76M
-87.47%-9.68M
-142.49%-8.99M
-140.09%-7.42M
-189.74%-6.04M
-158.04%-5.16M
-41.01%-3.71M
-78.41%-3.09M
32.13%-2.09M
0.68%-2.00M
---2.63M
---1.73M
---3.07M
---2.01M
Income tax
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Income after tax
-43.44%-40.55M
-138.84%-40.19M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
13.76%-27.32M
3.47%-27.98M
-22.54%-28.36M
-24.94%-33.01M
-7.20%-31.68M
-56.42%-28.98M
1.75%-23.14M
-27.91%-26.42M
-73.63%-29.55M
-54.53%-18.53M
-66.11%-23.55M
-183.97%-20.65M
-95.49%-17.02M
-52.97%-11.99M
-142.79%-14.18M
-16.69%-7.27M
-14.75%-8.71M
-43.06%-7.84M
4.06%-5.84M
10.12%-6.23M
-38.14%-7.59M
5.31%-5.48M
-27.34%-6.09M
-36.95%-6.94M
26.58%-5.49M
23.65%-5.79M
51.25%-4.78M
63.77%-5.06M
44.00%-7.48M
42.81%-7.58M
16.64%-9.81M
-44.37%-13.98M
-48.63%-13.36M
-78.60%-13.25M
-94.62%-11.76M
-87.47%-9.68M
-142.49%-8.99M
-140.09%-7.42M
-189.74%-6.04M
-158.04%-5.16M
-41.01%-3.71M
-78.41%-3.09M
32.13%-2.09M
0.68%-2.00M
---2.63M
---1.73M
---3.07M
---2.01M
Net income from continuous operations
-43.44%-40.55M
-138.84%-40.19M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
13.76%-27.32M
3.47%-27.98M
-22.54%-28.36M
-24.94%-33.01M
-7.20%-31.68M
-56.42%-28.98M
1.75%-23.14M
-27.91%-26.42M
-73.63%-29.55M
-54.53%-18.53M
-66.11%-23.55M
-183.97%-20.65M
-95.49%-17.02M
-52.97%-11.99M
-142.79%-14.18M
-16.69%-7.27M
-14.75%-8.71M
-43.06%-7.84M
4.06%-5.84M
10.12%-6.23M
-38.14%-7.59M
5.31%-5.48M
-27.34%-6.09M
-36.95%-6.94M
26.58%-5.49M
23.65%-5.79M
51.25%-4.78M
63.77%-5.06M
44.00%-7.48M
42.81%-7.58M
16.64%-9.81M
-44.37%-13.98M
-48.63%-13.36M
-78.60%-13.25M
-94.62%-11.76M
-87.47%-9.68M
-142.49%-8.99M
-140.09%-7.42M
-189.74%-6.04M
-158.04%-5.16M
-41.01%-3.71M
-78.41%-3.09M
32.13%-2.09M
0.68%-2.00M
---2.63M
---1.73M
---3.07M
---2.01M
Non-recurring net income
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
-43.44%-40.55M
-138.84%-40.19M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
19.84%-27.32M
3.47%-27.98M
-3.51%-28.36M
-24.94%-33.01M
-15.33%-34.08M
-56.42%-28.98M
-16.31%-27.39M
-27.91%-26.42M
-73.63%-29.55M
-54.53%-18.53M
-66.11%-23.55M
-129.89%-20.65M
-52.23%-17.02M
-52.97%-11.99M
-142.79%-14.18M
-44.14%-8.98M
-3.01%-11.18M
-43.06%-7.84M
4.06%-5.84M
10.12%-6.23M
-97.60%-10.85M
5.31%-5.48M
-27.34%-6.09M
-36.95%-6.94M
26.58%-5.49M
23.65%-5.79M
51.25%-4.78M
63.77%-5.06M
44.00%-7.48M
42.81%-7.58M
16.64%-9.81M
-44.37%-13.98M
-48.63%-13.36M
-78.60%-13.25M
-94.62%-11.76M
-87.47%-9.68M
-142.49%-8.99M
-140.09%-7.42M
-189.74%-6.04M
-158.04%-5.16M
-41.01%-3.71M
-78.41%-3.09M
32.13%-2.09M
0.68%-2.00M
---2.63M
---1.73M
---3.07M
---2.01M
Preferred share dividend
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
-100.00%0.00
----
--2.40M
--0.00
--4.25M
----
--0.00
--0.00
--0.00
----
-100.00%0.00
----
--0.00
--1.26M
-24.25%2.47M
----
----
----
--3.27M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to common shareholders
-43.44%-40.55M
-138.84%-40.19M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
19.84%-27.32M
3.47%-27.98M
-3.51%-28.36M
-24.94%-33.01M
-15.33%-34.08M
-56.42%-28.98M
-16.31%-27.39M
-27.91%-26.42M
-73.63%-29.55M
-54.53%-18.53M
-66.11%-23.55M
-129.89%-20.65M
-52.23%-17.02M
-52.97%-11.99M
-142.79%-14.18M
-44.14%-8.98M
-3.01%-11.18M
-43.06%-7.84M
4.06%-5.84M
10.12%-6.23M
-97.60%-10.85M
5.31%-5.48M
-27.34%-6.09M
-36.95%-6.94M
26.58%-5.49M
23.65%-5.79M
51.25%-4.78M
63.77%-5.06M
44.00%-7.48M
42.81%-7.58M
16.64%-9.81M
-44.37%-13.98M
-48.63%-13.36M
-78.60%-13.25M
-94.62%-11.76M
-87.47%-9.68M
-142.49%-8.99M
-140.09%-7.42M
-189.74%-6.04M
-158.04%-5.16M
-41.01%-3.71M
-78.41%-3.09M
32.13%-2.09M
0.68%-2.00M
---2.63M
---1.73M
---3.07M
---2.01M
Basic earnings per share
36.82%-2.44
-3.28%-2.93
59.64%-3.96
84.32%-3.59
99.80%-3.86
99.52%-2.84
99.64%-9.82
99.61%-22.88
77.50%-1.93K
94.33%-591.07
75.18%-2.74K
57.74%-5.84K
64.95%-8.57K
67.83%-10.42K
73.61%-11.04K
57.29%-13.82K
46.26%-24.45K
28.92%-32.38K
36.89%-41.82K
46.36%-32.36K
68.71%-45.50K
80.96%-45.56K
94.27%-66.27K
99.83%-60.33K
97.60%-145.45K
97.09%-239.28K
97.01%-1.16M
0.46%-36.41M
86.94%-6.06M
85.45%-8.23M
14.13%-38.71M
25.84%-36.58M
-11.20%-46.42M
30.47%-56.54M
66.08%-45.08M
73.43%-49.32M
86.87%-41.75M
82.85%-81.32M
70.70%-132.88M
59.68%-185.60M
31.84%-317.98M
-4.84%-474.25M
14.99%-453.50M
-1.75%-460.28M
-19.67%-466.50M
-19.33%-452.36M
-13.03%-533.44M
19.09%-452.36M
36.16%-389.81M
36.09%-379.08M
50.53%-471.96M
13.56%-559.07M
46.80%-610.57M
27.20%-593.19M
---954.11M
---646.78M
---1.15B
---814.85M
Diluted earnings per share
36.82%-2.44
-3.28%-2.93
59.64%-3.96
84.32%-3.59
99.80%-3.86
99.52%-2.84
99.64%-9.82
99.61%-22.88
77.50%-1.93K
94.33%-591.07
75.18%-2.74K
57.74%-5.84K
64.95%-8.57K
67.83%-10.42K
73.61%-11.04K
57.29%-13.82K
46.26%-24.45K
28.92%-32.38K
36.89%-41.82K
46.36%-32.36K
68.71%-45.50K
80.96%-45.56K
94.27%-66.27K
99.83%-60.33K
97.60%-145.45K
97.09%-239.28K
97.01%-1.16M
0.46%-36.41M
86.94%-6.06M
85.45%-8.23M
14.13%-38.71M
25.84%-36.58M
-11.20%-46.42M
30.47%-56.54M
66.08%-45.08M
73.43%-49.32M
86.87%-41.75M
82.85%-81.32M
70.70%-132.88M
59.68%-185.60M
31.84%-317.98M
-4.84%-474.25M
14.99%-453.50M
-1.75%-460.28M
-19.67%-466.50M
-19.33%-452.36M
-13.03%-533.44M
19.09%-452.36M
36.16%-389.81M
36.09%-379.08M
50.53%-471.96M
13.56%-559.07M
46.80%-610.57M
27.20%-593.19M
---954.11M
---646.78M
---1.15B
---814.85M
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Tonix Pharmaceuticals Holding Corp's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing TNXP stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Tonix Pharmaceuticals Holding Corp's revenue at year end?

Tonix Pharmaceuticals Holding Corp reported 13.11M in revenue for fiscal year 2025, up from 10.09M in the previous year.

How much revenue did Tonix Pharmaceuticals Holding Corp report in the most recent quarter?

Tonix Pharmaceuticals Holding Corp reported 13.54M in revenue for the most recent quarter, an increase of 577.88% year over year.

What was Tonix Pharmaceuticals Holding Corp's net income for the year?

Tonix Pharmaceuticals Holding Corp posted -124.02M in net income for fiscal year 2025.

How much net income did Tonix Pharmaceuticals Holding Corp post in the last quarter?

Tonix Pharmaceuticals Holding Corp reported -40.55M in net income for the latest quarter。

What was Tonix Pharmaceuticals Holding Corp's annual operating profit?

Tonix Pharmaceuticals Holding Corp's operating income was -125.70M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.